Ziad Fehmi, Undergraduate Researcher

Undergraduate Researcher
University of Michigan, United States

Disclosure information not submitted.

Presentation(s):

• THY1 confers proliferative advantages and therapy resistance in Glioblastoma.

  Sunday, May 5, 2024
  2:49 PM – 2:51 PM CT